Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)
Completed
Conditions studied: Chronic Obstructive Pulmonary Disease
In brief
The purpose of this study is to compare the ability of two types of white blood cells to eat dead host cells, and how this process affects their ability to protect the body from infection. The two cell types are monocytes, a cell in the bloodstream, and alveolar macrophages, a cell in the lung that is ultimately derived from monocytes
Key facts
- Study ID
- NCT01099410
- Run by
- VA Office of Research and Development
- People needed
- 17
- Starts
- 2010-02-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2016-01-06
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Veteran or non-Veteran
- Able to give informed consent
You may not qualify if…
- Unstable heart disease
- Other systemic disease and unlikely to survive at least 2 years
- Mental incompetence
- Prednisone >20 mg/day
- Participation in another interventional protocol within last 6 weeks
- Asthma
- Cystic fibrosis
- Clinically significant bronchiectasis
- Lung cancer or any cancer not in remission for at least 5 years
- Other inflammatory or fibrotic lung disease
- Use of antibiotics for a lung infection within the past 4 weeks
- Autoimmune disease, i.e., Rheumatoid arthritis, systemic lupus erythematosus, autoimmune hepatitis, Crohn's disease or other
Where it is running
- VA Ann Arbor Healthcare System, Ann Arbor, MI — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.